PRKAA2 and neoplasm: By inhibiting cell growth and proliferation, and by opposing the activation of pathways that promote those processes such as the mTORC1 pathway, it seems reasonable that AMPK would oppose the initiation of tumours, thus acting as a tumour suppressor.